Abstract

XPF endonuclease is one of the most important DNA repair proteins. Encoded by XPF/ERCC4, XPF provides the enzymatic activity of XPF-ERCC1 heterodimer, an endonuclease that incises at the 5’ side of various DNA lesions. XPF is essential for nucleotide excision repair (NER) and interstrand crosslink repair (ICLR). XPF/ERCC4 mutations are associated with several human diseases: Xeroderma Pigmentosum (XP), Segmental Progeria (XFE), Fanconi Anemia (FA), Cockayne Syndrome (CS), and XP/CS combined disease (XPCSCD). Most affected individuals are compound heterozygotes for XPF/ERCC4 mutations complicating the identification of genotype/phenotype correlations. We report a detailed overview of NER and ICLR functional studies in human XPF-KO (knock-out) isogenic cells expressing six disease-specific pathogenic XPF amino acid substitution mutations. Ultraviolet (UV) sensitivity and unscheduled DNA synthesis (UDS) assays provide the most reliable information to discern mutations associated with ICLR impairment from mutations related to NER deficiency, whereas recovery of RNA synthesis (RRS) assays results hint to a possible role of XPF in resolving R-loops. Our functional studies demonstrate that a defined cellular phenotype cannot be easily correlated to each XPF mutation. Substituted positions along XPF sequences are not predictive of cellular phenotype nor reflect a particular disease. Therefore, in addition to mutation type, allelic interactions, protein stability and intracellular distribution of mutant proteins may also contribute to alter DNA repair pathways balance leading to clinically distinct disorders.

Highlights

  • The human XPF/ERCC4 gene is located in 16p13.1-p13.2 and encodes for the 916 amino acids longXPF protein, [1] which forms a stable heterodimer with ERCC1 in order to constitute a structure-specific endonuclease that incises the 5’ side of several types of DNA lesions

  • The FANCore complex is formed by seven Fanconi Anemia (FA) proteins and six FA-associated proteins whose functions are to activate through monoubiquitination the heterodimer formed by FANCD2 and FANCI proteins (ID complex) to enable its relocation to the DNA damage site [34] where it allows the recruitment of SLX4-XPF-ERCC1 to incise and unhook the interstrand crosslinks (ICLs)

  • TALEN technology was used to edit the genome of HEK 293T cells to generate an XPF/ERCC4-/human cell line (XPF-KO)

Read more

Summary

Introduction

The human XPF/ERCC4 gene is located in 16p13.1-p13.2 and encodes for the 916 amino acids long. Mutation in XPF/ERCC4 can produce a progeria-like phenotype (XFE) characterized by the failure of the mutant XPF protein to properly translocate to the nucleus and to be recruited to sites of active DNA repair. The FANCore complex is formed by seven FA proteins and six FA-associated proteins whose functions are to activate through monoubiquitination the heterodimer formed by FANCD2 and FANCI proteins (ID complex) to enable its relocation to the DNA damage site [34] where it allows the recruitment of SLX4-XPF-ERCC1 to incise and unhook the ICLs. Despite several other endonucleases being involved in ICLSs processing [12], the identification of FA patients carrying XPF/ERCC4 mutations suggests that XPF-ERCC1 endonuclease has a major role in ICL repair [35]. Concerning the wide range of diseases associated with changes in XPF protein due to its crucial role in several DNA repair pathways, the objective of this study was to better understand the role of XPF in DNA repair and human disease by analyzing the genotype-phenotype correlation of XPF/ERCC4 pathogenic variants causing XP, FA, CS, XFE or CS/XP in a genetically homogeneous background

Cell Culture
Generation of XPF-KO CELL Line
Western Blot Analysis
Characterization of the Selected XPF-KO Clone
Generation of the XPF Mutant Variants
Ultraviolet C Sensitivity Survival Assay
Unscheduled DNA Synthesis Assay
Recovery of RNA Synthesis Assay
2.10. Diepoxybutinate Sensitivity Survival Assay
2.12. Chromosome Fragility by the Flow Cytometric Micronucleus Test
Results and Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call